Biorestorative Therapies (OTCMKTS:BRTXQ) Hits New 1-Year High at $1.85

BioRestorative Therapies, Inc. stock price. (OTCMKTS:BRTXQ – Get Your Free Report ) hit a new 52-week high during trading on Tuesday . The company traded as high as $1.85 and last traded at $1.75, with a volume of 14381 shares traded. Shares previously closed at $1.80.

The stock of biorestorative therapies decreased by 5.7%

The firm has a market cap of $2.71 billion, a P/E ratio of -1.54 and a beta of 102.36. The company has a 50 day moving average of $1.59 and a two hundred day moving average of $1.51.

BioRestorative Therapies Company Profile

(Get a free report)

BioRestorative Therapies, Inc develops therapeutic products using cellular and tissue based protocols primarily involving adult stem cells. The company’s two core programs are related to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program includes a lead cell therapy candidate, BRTX-100, a product formulated from autologous (or human) mesenchymal stem cells cultured from a patient’s bone marrow and intended for the non-surgical treatment of painful lumbosacral disc disorders. .

See Also

Receive daily news and reviews for biorestorative therapies – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for BioRestorative Therapies and related companies with MarketBeat.com ‘s FREE daily newsletter.